Operait helps healthcare, biotech, pharma, medtech, and regulated-market companies move faster through fundraising, BD, M&A, market entry, launches, turnarounds, and AI transformation — without the cost or delay of a full-time executive hire.
Led by Jonathan Berlent — senior operator with 20+ years across healthcare, life sciences, regulated markets. Expertise: business growth, operations, M&A, business development.
You're closing a Series A / B / C, and you need an experienced operator to refine the narrative, stress-test your assumptions, and signal momentum to investors.
You're evaluating a strategic acquisition, structuring a BD deal, or entering a new partnership. You need experienced deal architecture and cross-functional orchestration.
You're entering a new market, launching a product, or scaling commercial infrastructure. You need a fractional executive to build and execute the playbook.
Your business is underperforming. You need diagnostic clarity on constraints, a realistic recovery plan, and hands-on execution to restore momentum.
You're integrating AI into your business model — operations, customer experience, or strategy. You need an advisor who understands both AI and regulated markets.
You need external strategic counsel, quarterly advisory sprints, or a trusted sounding board for major decisions. We work with boards and investors, not just founders.
We diagnose constraints, build executable clarity, and orchestrate execution across product, commercial, pipeline, and partnerships. Strategic advisor with operating authority.
Intensive 4-week engagement: Diagnosis of growth constraints, clear strategy framework, executable roadmap, and immediate tactical execution. Ideal for founders, boards, and capital-raising moments.
Fractional President, COO, or SVP role: Ongoing leadership and execution across capital strategy, portfolio decisions, and team coordination. Report directly to CEO or board. Scale from part-time to full-time.
Quarterly advisory sprints or standing board role: Strategic counsel on capital, partnerships, market opportunity, and operational risk. Deep engagement without full-time employment.
AI-powered operational acceleration for biotech, pharma, and regulated markets. Process optimization, market intelligence, deal analysis, and board materials — delivered fast and at lower cost than traditional consulting.
Learn about 3xAI →AI-augmented acquisition and integration platform for biotech and pharma companies. Portfolio analysis, target identification, valuation modeling, and post-acquisition optimization.
Learn about TENxAI →Refined fundraising narrative, investor pitch, and capital strategy. Closed capital faster with higher valuations and better terms.
Clear asset prioritization, deprioritization roadmap, and pipeline strategy. Kill underperforming assets faster; double down on winners.
Cross-functional alignment, team clarity, execution velocity. Move faster. Reduce friction. Ship results.
Strategic deal sourcing, target evaluation, deal architecture, and post-close integration. Closed transactions. Built teams. Created value.
Go-to-market strategy, market entry playbook, team building, and launch execution. Scaled revenue. Hired teams. Built infrastructure.
External perspective. Strategic counsel. De-risking major decisions. Trusted advisor to boards and founders.
Operating Executive & Strategic Advisor | Biotech & Specialty Pharma | Clinical-Stage to Commercial
Jonathan is a senior operator with 20+ years building and scaling biotech, pharma, and regulated-market businesses. Trusted by boards, founders, and investors to diagnose growth constraints, execute operational recovery, and close strategic partnerships and acquisitions.
What He Brings: Clinical development strategy, regulatory pathway optimization, commercial infrastructure build, M&A deal architecture, business development strategy, capital formation, and team leadership across clinical, manufacturing, commercial, and investor-facing functions.
Recent Work: SVP Strategy at Merakris Therapeutics (regenerative medicine, clinical-stage allograft + Phase 2b biologic); President of Sentiss Pharmaceuticals North America (sterile ophthalmic manufacturing + M&A); advisor to biotech founders, boards, and institutional investors on portfolio strategy, capital formation, and partnership execution.
Education: NYU Stern MBA; University of Michigan (Economics). Email: jonathan@operait.co
Four engagement models to fit your needs, timeline, and budget. All built on the same principle: immediate impact + hands-on execution.
Intensive diagnostic + roadmap build. For founders facing a critical decision, boards needing fresh perspective, or companies in capital-raise mode. Deliverables: diagnosis, strategy, 90-day roadmap, immediate tactical action.
Quarterly advisory sprints or standing board role. For founders, boards, and investors needing trusted external counsel on capital, partnerships, and strategy. Reports to board or CEO. Flexible scope and commitment.
Deep operational engagement on a defined strategic objective: capital raise, M&A execution, market entry, turnaround, or AI integration. Hands-on work alongside your team. Transition to ongoing role possible.
Fractional President, COO, SVP, or Chief Strategy Officer. Ongoing operational leadership, capital strategy, and team coordination. Report directly to CEO or board. Scale from part-time to full-time as needs evolve.
Tell us a bit about what you're working on. We'll get back to you within 24 hours to discuss next steps.
Thanks for sending that over. We typically respond within 24 hours. In the meantime, feel free to book a call directly — no need to wait.